PURPOSE: To assess the prevalence of depression and fatigue symptoms in head and neck cancer patients during radiotherapy treatment and relate them symptoms with these patients' quality of life. METHOD: This is a prospective study. The Beck Depression Inventory (BDI), Piper Fatigue Scale-revised and Functional Assessment Cancer Therapy Head and Neck (FACT-H&N) were applied to 41 head and neck cancer patients at three times: at the start of treatment (T1), approximately 15 days after the start of treatment (T2) and at the end of treatment (T3), approximately 30 days after the start of the radiotherapy. RESULTS: The mean BDI and PIPER increased during the radiotherapy treatment. BDI scores did not demonstrate the presence of depression, although the number of symptoms increased, and the presence of fatigue rose as treatment advanced. The mean FACT H&N decreased in the middle and at the end of treatment, indicating worsening in these patients' Quality of Life. CONCLUSIONS: Depression and fatigue symptoms increased during radiotherapy treatment, while QoL levels decreased. This demonstrates that these symptoms are strongly correlated and that their presence negatively influenced QoL. At the start of treatment, nurses need to advise patients and plan care, offering interventions to decrease these symptoms and improve QoL.
PURPOSE: To assess the prevalence of depression and fatigue symptoms in head and neck cancerpatients during radiotherapy treatment and relate them symptoms with these patients' quality of life. METHOD: This is a prospective study. The Beck Depression Inventory (BDI), Piper Fatigue Scale-revised and Functional Assessment Cancer Therapy Head and Neck (FACT-H&N) were applied to 41 head and neck cancerpatients at three times: at the start of treatment (T1), approximately 15 days after the start of treatment (T2) and at the end of treatment (T3), approximately 30 days after the start of the radiotherapy. RESULTS: The mean BDI and PIPER increased during the radiotherapy treatment. BDI scores did not demonstrate the presence of depression, although the number of symptoms increased, and the presence of fatigue rose as treatment advanced. The mean FACT H&N decreased in the middle and at the end of treatment, indicating worsening in these patients' Quality of Life. CONCLUSIONS:Depression and fatigue symptoms increased during radiotherapy treatment, while QoL levels decreased. This demonstrates that these symptoms are strongly correlated and that their presence negatively influenced QoL. At the start of treatment, nurses need to advise patients and plan care, offering interventions to decrease these symptoms and improve QoL.
Authors: Jason Y K Chan; Lannah L Lua; Heather H Starmer; Daniel Q Sun; Elizabeth S Rosenblatt; Christine G Gourin Journal: Laryngoscope Date: 2011-05-03 Impact factor: 3.325
Authors: P Infante-Cossio; E Torres-Carranza; A Cayuela; E Hens-Aumente; P Pastor-Gaitan; J L Gutierrez-Perez Journal: Int J Oral Maxillofac Surg Date: 2009-10 Impact factor: 2.789
Authors: G I Andreoni; D B Veneziano; O Giannotti Filho; C Marigo; A P Mirra; L A Fonseca Journal: Rev Saude Publica Date: 2001-08 Impact factor: 2.106
Authors: Johannes A Langendijk; Patricia Doornaert; Irma M Verdonck-de Leeuw; Charles R Leemans; Neil K Aaronson; Ben J Slotman Journal: J Clin Oncol Date: 2008-08-01 Impact factor: 44.544
Authors: Christopher Wratten; Janice Kilmurray; Sharon Nash; Michael Seldon; Christopher S Hamilton; Peter C O'Brien; J W Denham Journal: Int J Radiat Oncol Biol Phys Date: 2004-05-01 Impact factor: 7.038
Authors: Canhua Xiao; Jonathan J Beitler; Kristin A Higgins; Karen Conneely; Bhakti Dwivedi; Jennifer Felger; Evanthia C Wommack; Dong M Shin; Nabil F Saba; Luke Yeeloo Ong; Jeanne Kowalski; Deborah W Bruner; Andrew H Miller Journal: Brain Behav Immun Date: 2015-10-30 Impact factor: 7.217
Authors: Elise M Gane; Steven M McPhail; Anna L Hatton; Benedict J Panizza; Shaun P O'Leary Journal: Eur Arch Otorhinolaryngol Date: 2017-09-22 Impact factor: 2.503
Authors: Colin Lavigne; Harold Lau; George Francis; S Nicole Culos-Reed; Guillaume Y Millet; Rosie Twomey Journal: Eur J Appl Physiol Date: 2020-04-06 Impact factor: 3.078
Authors: Sara E McEwen; Aileen M Davis; Jennifer M Jones; Rosemary Martino; Ian Poon; Ana Maria Rodriguez; Jolie Ringash Journal: Implement Sci Date: 2015-01-09 Impact factor: 7.327
Authors: Juliana Maria de Paula Avelar; Adriana Cristina Nicolussi; Bruna Francielle Toneti; Helena Megumi Sonobe; Namie Okino Sawada Journal: Rev Lat Am Enfermagem Date: 2019-08-19